<?xml version="1.0" encoding="UTF-8"?>
<results title="test_trace">
 <result pre="Scholar search till 23 March 2020. Search terms were, COVID-19," exact="treatment" post="of coronavirus, COVID 19 and following terms; chloroquine, hydroxychloroquine,"/>
 <result pre="We discuss evidence regarding role of chloroquine and hydroxychloroquine in" exact="treatment" post="and prophylaxis, use of inhibitors of the renin angiotensin"/>
 <result pre="ibuprofen, unusual clinical features like gastrointestinal symptoms and interpretation of" exact="tests" post="for cardiac enzymes and biomarkers. Conclusions While our conclusions"/>
 <result pre="and Google Scholar till March 23, 2020 using the keywordsCOVID-19," exact="treatment" post="of coronavirus, COVID 19 and following terms; chloroquine, hydroxychloroquine,"/>
 <result pre="in clinical studies in humans. CQ did not prevent influenza" exact="infection" post="in a randomized, double-blind, placebo-controlled clinical trial [7]. Further,"/>
 <result pre="[7]. Further, there was no effect on patients with dengue" exact="infection" post="in a randomized controlled trial [8]. Of concern was"/>
 <result pre="replication and exacerbated fever in animal models of chikungunya virus" exact="infection" post="[9]. Also, patients with chikungunya virus infection had more"/>
 <result pre="of chikungunya virus infection [9]. Also, patients with chikungunya virus" exact="infection" post="had more chronic arthralgia when treated with CQ vs."/>
 <result pre="[11]. Against this background, CQ was evaluated in SARS CoV-2" exact="infection" post="and showed very good in vitro efficacy [12]. The"/>
 <result pre="and 16 patients served as controls. At day 6 post" exact="treatment" post="the proportion of patients who were negative for SARS"/>
 <result pre="trials are planned to study its role in prevention and" exact="treatment" post="of COVID-19 and at present, it is difficult to"/>
 <result pre="and low cost, it could be offered as an off-label" exact="treatment" post="to the patients with moderate to severe COVID-19 infection."/>
 <result pre="not mandatory, to avoid ibuprofen and other NSAIDs in COVID-19" exact="infection" post="and use acetaminophen instead for control of fever and"/>
 <result pre="with an angiotensin receptor blocker, losartan [22].As far as CVID-19" exact="infection" post="is concerned, the data on RAS activation or the"/>
 <result pre="incidence of hypokalaemia has been reported in patients with COVID-19" exact="infection" post="[23]. Despite these small studies suggesting the benefit of"/>
 <result pre="data, albeit scarce, from animal models and human studies that" exact="treatment" post="with ACE inhibitors and ARB could causeup regulation of"/>
 <result pre="Increased expression of ACE2 could theoretically increase the risk of" exact="infection" post="with SARS CoV-2. This could be a concern in"/>
 <result pre="have received renal transplant are at increased risk of COVID-19" exact="infection" post="and severity. Moreover, there are frequent renal function abnormalities"/>
 <result pre="troponin Ilevels are significantly increased in patients with severe SARS-CoV-2" exact="infection" post="compared to those with milder forms of disease [37]."/>
 <result pre="cardiomyocytes. American College of Cardiology recommends measuring troponin if the" exact="diagnosis" post="of acute MI is being considered on clinical grounds"/>
 <result pre="acute MI without corroborating evidence [38]. Similarly, patients with COVID-19" exact="infection" post="have elevated natriuretic peptides, significance of which is uncertain."/>
 <result pre="indicator of heart failure. 6.4 Testis Orchitis was reported in" exact="infection" post="with SARS CoV earlier [39]. ACE-2 receptors are present"/>
 <result pre="A7861981360536096115382 5KeyaertsE.LiS.VijgenL.RysmanE.VerbeeckJ.Van RanstM.MaesP.Antiviral activity of chloroquine against human coronavirus OC43" exact="infection" post="in newbornmiceAntimicrob Agents Chemother53820093416342110.1128/AAC.01509-0819506054 6InglotA.D.Comparison of the antiviral activity"/>
 <result pre="Infect Dis119201167768310.1016/S1473-3099(11)70065-221550310 8TricouV.MinhN.N.VanT.P.LeeS.J.FarrarJ.WillsB.TranH.T.SimmonsC.P.A randomized controlled trial of chloroquine for the" exact="treatment" post="of dengue in Vietnamese adultsPLoS Negl Trop Dis482010 Aug"/>
 <result pre="Trop Dis482010 Aug 10e78510.1371/journal.pntd.000078520706626 9RoquesP.ThibervilleS.D.Dupuis-MaguiragaL.LumF.M.LabadieK.MartinonF.GrasG.LebonP.NgL.F.P.de LamballerieX.Le GrandR.Paradoxical effect of chloroquine" exact="treatment" post="in enhancing chikungunya virus infectionViruses1052018E26810.3390/v10050268pii29772762 10De LamballerieX.BoissonV.ReynierJ.C.EnaultS.CharrelR.N.FlahaultA.RoquesP.Le GrandR.On chikungunya"/>
 <result pre="in enhancing chikungunya virus infectionViruses1052018E26810.3390/v10050268pii29772762 10De LamballerieX.BoissonV.ReynierJ.C.EnaultS.CharrelR.N.FlahaultA.RoquesP.Le GrandR.On chikungunya acute" exact="infection" post="and chloroquine treatmentVector Borne Zoonotic Dis86200883783910.1089/vbz.2008.004918620511 11SavarinoA.Use of chloroquine"/>
 <result pre="coronavirus (2019-nCoV) in vitroCell Res303202026927110.1038/s41422-020-0282-010-028232020029 13GautretHydroxychloroquine and azithromycin as a" exact="treatment" post="of COVID-19: results of an open-label non-randomized clinical trialInt"/>
 <result pre="March 2020 14GaoJ.TianZ.YangX.Breakthrough: chloroquine phosphate has shown apparent efficacy in" exact="treatment" post="of COVID-19 associated pneumonia in clinical studiesBiosci Trends1412020 Mar"/>
 <result pre="clinical studiesBiosci Trends1412020 Mar 16727310.5582/bst.2020.0104732074550 15SinghA.K.SinghA.ShaikhA.SinghR.MisraA.Chloroquine or Hydroxychloroquine in the" exact="treatment" post="of COVID-19 with or without Diabetes: a systematic search"/>
</results>
